About Rockland Immunochemicals
Rockland Immunochemicals, Inc. offers a robust catalog of antibodies to suit any project. No matter the context—basic research to disease therapy, phosphorylated to methylated, and beyond—Rockland embraces the challenge to design, produce, validate, and deliver the absolute best antibodies and life science reagents available in the market today.
Our laboratories have been in Pennsylvania for over 55 years. In this time, we have collaborated with premier research institutions and companies around the world.
Rockland products are guaranteed to give predictable, repeatable results. We are one of the most referenced companies in the industry and will continue collaborating with these world leaders to develop new and efficient products.
Rockland is an internationally acclaimed manufacturer and trusted partner. We take pride in our products and stand as a leader in antibody innovation. With over 13,000 products, we offer the most comprehensive selection of antibodies available. By creating our antibodies in-house, our products are guaranteed to give predictable, repeatable results. Protect your experiments with Rockland antibodies. Compromise elsewhere.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of Rockland Immunochemicals
Similar companies
News about Rockland Immunochemicals
Here you will find Rockland Immunochemicals Inc.
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Last viewed contents
Recipharm International Environmental Award 2012 won by Dr. Damia Barcelo - Director of Catalan Institute for Water Research awarded accolade in recognition of environmental research to minimise impact of pharmaceutical residues
Biochimex - Compiègne, France
Xerion Pharmaceuticals AG and Stemline Therapeutics Announce Collaboration on Cancer Stem Cells
Novartis: PTK/ZK CONFIRM 1 Study Shows Positive Drug Effects in Phase III Study in Metastatic Colorectal Cancer
Bausch & Lomb and Galapagos sign agreement to collaborate on ophthalmic disease research
Phytopathology
Caught by a hair - Crime fighters could have a new tool at their disposal
BBCH-scale_(leafy_vegetables_not_forming_heads)
AMRI promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing
Silence Therapeutics' Group CEO resigns
BBCH-scale_(other_brassica_vegetables)
